Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Paola Costi

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|December 23, 2025
Mass Spectrometry Proteomics: A Key to Faster Drug DiscoveryLorenzo Tagliazucchi, Maria Paola Costi
Gynecologic Oncology|April 6, 2010
Drug resistance in ovarian cancer: biomarkers and treatments Highlights from the DROC meeting held in Modena (Italy) on the 19th and 20th of February 2009. Scientific topics discussed at the meeting are reported in the present issueMaria Paola Costi, Robert Zeillinger
Nature|April 17, 2009
Biochemistry: Anchors awayMaria Paola Costi, Stefania Ferrari
Chemmedchem|February 14, 2008
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme familyStefania Ferrari, Valeria Losasso, Maria Paola Costi
ACS Infectious Diseases|October 29, 2024
One Health and Vector-Borne Parasitic Diseases Virtual Special IssueMaria Paola Costi, Anabela Cordeiro da Silva
Chemmedchem|March 8, 2008
Opening opportunities for new drugs against neglected diseasesMaria Paola Costi, Donatella Taramelli, Dolores González-Pacanowska
Drug Discovery Today|November 29, 2016
Target-based approaches for the discovery of new antimycobacterial drugsChiara Borsari, Stefania Ferrari, Alberto Venturelli, et al.
Trends in Parasitology|May 23, 2017
The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a DifferenceRaymond J Pierce, Jane MacDougall, Rob Leurs, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitorsDonatella Tondi, Samuele Calò, Brian K Shoichet, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 22, 2003
Quinoxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]-benzoylglutamates and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]-benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activitiesMario Loriga, Sandra Piras, Giuseppe Paglietti, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|December 23, 2025
Mass Spectrometry Proteomics: A Key to Faster Drug DiscoveryLorenzo Tagliazucchi, Maria Paola Costi
Gynecologic Oncology|April 6, 2010
Drug resistance in ovarian cancer: biomarkers and treatments Highlights from the DROC meeting held in Modena (Italy) on the 19th and 20th of February 2009. Scientific topics discussed at the meeting are reported in the present issueMaria Paola Costi, Robert Zeillinger
Nature|April 17, 2009
Biochemistry: Anchors awayMaria Paola Costi, Stefania Ferrari
Chemmedchem|February 14, 2008
Sequence-based identification of specific drug target regions in the thymidylate synthase enzyme familyStefania Ferrari, Valeria Losasso, Maria Paola Costi
ACS Infectious Diseases|October 29, 2024
One Health and Vector-Borne Parasitic Diseases Virtual Special IssueMaria Paola Costi, Anabela Cordeiro da Silva
Chemmedchem|March 8, 2008
Opening opportunities for new drugs against neglected diseasesMaria Paola Costi, Donatella Taramelli, Dolores González-Pacanowska
Drug Discovery Today|November 29, 2016
Target-based approaches for the discovery of new antimycobacterial drugsChiara Borsari, Stefania Ferrari, Alberto Venturelli, et al.
Trends in Parasitology|May 23, 2017
The Future of Drug Development for Neglected Tropical Diseases: How the European Commission Can Continue to Make a DifferenceRaymond J Pierce, Jane MacDougall, Rob Leurs, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2010
Structural study of phenyl boronic acid derivatives as AmpC beta-lactamase inhibitorsDonatella Tondi, Samuele Calò, Brian K Shoichet, et al.
Farmaco (Societa Chimica Italiana : 1989)|February 22, 2003
Quinoxaline chemistry. Part 15. 4-[2-Quinoxalylmethylenimino]-benzoylglutamates and -benzoates, 4-[2-quinoxalylmethyl-N-methylamino]-benzoylglutamates as analogues of classical antifolate agents. Synthesis, elucidation of structures and in vitro evaluation of antifolate and anticancer activitiesMario Loriga, Sandra Piras, Giuseppe Paglietti, et al.
Pageof 10